1. RODNA
  2. CONICET
  3. CONICET
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceCONICET-
dc.creatorAarntzen, Erik H. J. G.-
dc.creatorSrinivas, Mangala-
dc.creatorBonetto, Fernando Jose-
dc.creatorCruz, Luis J.-
dc.creatorVerdijk, Pauline-
dc.creatorSchreibelt, Gerty-
dc.creatorVan de Rakt, Mandy-
dc.creatorLesterhuis, W. Joost-
dc.creatorVan Riel, Maichel-
dc.creatorPunt, Cornelius J. A.-
dc.creatorAdema, Gosse J.-
dc.creatorHeerschap, Arend-
dc.creatorFigdor, Carl G.-
dc.creatorOyen, Wim J.-
dc.creatorde Vries, I. Jolanda M.-
dc.date2015-09-23T18:51:20Z-
dc.date2015-09-23T18:51:20Z-
dc.date2013-03-15-
dc.date2016-03-30 10:35:44.97925-03-
dc.date.accessioned2019-04-29T15:37:45Z-
dc.date.available2019-04-29T15:37:45Z-
dc.date.issued2013-03-15-
dc.identifierAarntzen, Erik H. J. G.; Srinivas, Mangala; Bonetto, Fernando Jose; Cruz, Luis J.; Verdijk, Pauline; et al.; Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells; American Association for Cancer Research; Clinical Cancer Research; 19; 15-3-2013; 1525-1533-
dc.identifier1078-0432-
dc.identifierhttp://hdl.handle.net/11336/2073-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/298063-
dc.descriptionAnti-cancer dendritic cell (DC) vaccines require the DC to relocate to lymph nodes (LN) to trigger immune responses. However, these migration rates are typically very poor. Improving the targeting of ex vivo generated DC to LN might increase vaccine efficacy and reduce costs. We investigated DC migration in vivo in humans in different conditions.-
dc.descriptionFil: Aarntzen, Erik H. J. G.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; Leiden University. Department of Endocrinology; Países Bajos;-
dc.descriptionFil: Srinivas, Mangala. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.descriptionFil: Bonetto, Fernando Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET- Santa Fe. Instituto de Desarrollo Tecnológico para la Industria Química (i); Argentina;-
dc.descriptionFil: Cruz, Luis J.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; Leiden University. Department of Endocrinology; Países Bajos;-
dc.descriptionFil: Verdijk, Pauline. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; National Institute for Public Health and the Environment. Departament of Vaccinology; Países Bajos;-
dc.descriptionFil: Schreibelt, Gerty. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.descriptionFil: Van de Rakt, Mandy. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.descriptionFil: Lesterhuis, W. Joost. Radboud University Nijmegen Medical Centre. Department of Medical Oncology ; Países Bajos;-
dc.descriptionFil: Van Riel, Maichel. Radboud Universiteit Nijmegen Medical Centre Department of Nuclear Medicine; Países Bajos;-
dc.descriptionFil: Punt, Cornelius J. A.. Academic Medical Centre. Department of Medical Oncology; Países Bajos;-
dc.descriptionFil: Adema, Gosse J.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.descriptionFil: Heerschap, Arend. Radboud Universiteit Nijmegen. Department of Radiology; Paí­ses Bajos;-
dc.descriptionFil: Figdor, Carl G.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.descriptionFil: Oyen, Wim J.. Leiden University. Department of Endocrinology; Países Bajos;-
dc.descriptionFil: de Vries, I. Jolanda M.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherAmerican Association for Cancer Research-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/doi:10.1158/1078-0432.CCR-12-1879-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://clincancerres.aacrjournals.org/content/19/6/1525.long-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.source.urihttp://hdl.handle.net/11336/2073-
dc.subjectDendritic cells-
dc.subject19F magnetic resonance imaging-
dc.subjectMigration-
dc.subjectImmunotherapy-
dc.subjectOncología-
dc.subjectMedicina Clínica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.subjectRadiología, Medicina Nuclear y Diagnóstico por Imágenes-
dc.subjectMedicina Clínica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleTargeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro sencillo del ítem